2016 Innovation Competition (Boston, MA)

Better than sliced... brain

Concept or business name.

ImmunoChem Therapeutics

Elevator Pitch

We are a clinical stage start-up with two drug candidates targeting brain inflammation, the main cause of neuronal/ synaptic damage and mental decline in brain trauma, Alzheimer’s disease, and other neurodegenerative disorders.

Victor Shifrin, CEO, ImmunoChem Therapeutics, LLC tel. 617-872-0639 vshifrin@ic-rx.com

Go back to "Submit an Opportunity"